Ladel C H, Flesch I E, Arnoldi J, Kaufmann S H
Department of Immunology, University of Ulm, Germany.
J Immunol. 1994 Oct 1;153(7):3116-22.
Mutant mice with a defined genetic defect in the beta 2-microglobulin (beta 2m) or the H2-I-A beta chain, which are virtually devoid of functional CD8 or CD4 alpha beta T cells, respectively, were employed for analyzing immune mechanisms involved in acquired resistance against Listeria monocytogenes. Although the lethal dose of L. monocytogenes was markedly lower for either mouse mutant as compared with their heterozygous control littermates, both beta m -/- and A beta -/- mutants were able to resolve low dose infection. However, in both mouse mutants, the course of disease was exacerbated and clearance was markedly delayed. Vaccine induced immunity against a secondary high dose infection lethal for naive animals was also impaired in beta 2m -/- and A beta -/- mice. However, both mutant mice were still capable of controlling secondary infection. Based on numbers of L. monocytogenes organisms in spleens, beta 2m -/- mutants suffered more dramatically from primary and secondary infection than A beta -/- mice. Ag-induced IFN-gamma secretion was impaired during the early phase of infection in beta 2m -/- mice and at later stages in A beta -/- mice. Modulation of gamma delta T cells by mAb treatment led to significant increase in bacterial load of spleens in both beta 2m -/- and A beta -/- mice. Finally, the development of granulomatous lesions was markedly affected in both mutants. In beta 2m -/- mutants, infiltrative lesions appeared and in A beta -/- mice few inflammatory islets with necrotic centers developed. These data demonstrate the importance of both MHC I- and MHC II-dependent immune mechanisms in acquired resistance to L. monocytogenes and point to the necessity of a coordinated interaction between CD8 and CD4 alpha beta T cells (and probably gamma delta T cells) in anti-L. monocytogenes resistance.
利用在β2-微球蛋白(β2m)或H2-I-Aβ链中存在特定基因缺陷的突变小鼠,它们实际上分别缺乏功能性CD8或CD4αβT细胞,来分析参与获得性抗单核细胞增生李斯特菌抗性的免疫机制。尽管与它们的杂合对照同窝小鼠相比,这两种小鼠突变体对单核细胞增生李斯特菌的致死剂量明显更低,但βm-/-和Aβ-/-突变体都能够解决低剂量感染。然而,在这两种小鼠突变体中,疾病进程都加剧了,清除明显延迟。疫苗诱导的针对对未感染动物致死的二次高剂量感染的免疫力在β2m-/-和Aβ-/-小鼠中也受损。然而,这两种突变小鼠仍然能够控制二次感染。根据脾脏中单核细胞增生李斯特菌的数量,β2m-/-突变体在原发性和继发性感染中比Aβ-/-小鼠遭受的影响更大。在β2m-/-小鼠感染早期和Aβ-/-小鼠感染后期,抗原诱导的IFN-γ分泌受损。用单克隆抗体处理调节γδT细胞导致β2m-/-和Aβ-/-小鼠脾脏中的细菌载量显著增加。最后,两种突变体中肉芽肿性病变的发展都受到明显影响。在β2m-/-突变体中出现浸润性病变,在Aβ-/-小鼠中形成了一些有坏死中心的炎性小岛。这些数据证明了MHC I和MHC II依赖性免疫机制在获得性抗单核细胞增生李斯特菌抗性中的重要性,并指出了CD8和CD4αβT细胞(可能还有γδT细胞)在抗单核细胞增生李斯特菌抗性中协同相互作用的必要性。